Invitae’s chromosomal microarray analysis (CMA) can determine whether a miscarriage, an intrauterine fetal demise (IUFD), or a stillbirth was caused by a chromosome abnormality.
Invitae also offers reproductive karyotyping to determine if a couples’ history of recurrent pregnancy loss, miscarriage, or infertility has been caused by a balanced translocation.
Pregnancy loss chromosomal microarray analysis (CMA) analyzes products of conception (POC) to determine whether a miscarriage, an intrauterine fetal demise (IUFD), or a stillbirth was caused by a chromosome abnormality.
Pregnancy loss chromosomal microarray analysis (CMA) analyzes products of conception (POC) tissue preserved in a formalin-fixed, paraffin-embedded (FFPE) block or unstained slides to determine whether a miscarriage, an intrauterine fetal demise (IUFD), or a stillbirth was caused by a chromosome abnormality.
Estimate your out-of-pocket cost for Invitae tests related to a personal or family history of breast, ovarian, colorectal, or uterine cancer.
The amount shown above is an estimate of your out-of-pocket cost based upon the information you entered about your health insurance coverage. It is not a confirmation that the test has been authorized by your insurance provider. Your final cost may vary based upon your health plan design, deductible, co-insurance, and out-of-pocket limits. Learn More >
As part of Invitae’s dedication to making high-quality genetic testing affordable and accessible, we also offer a patient pre-pay option of $250. Learn More >
We could not determine an out-of-pocket estimate. Please contact us for assistance.
